Congratulations to EB 2021 Poster Awardess from the Division for Drug Discovery and Development!
1st place, “Sympathetic and Parasympathetic Regulation of NF-κB by GPCRs through the modulation of interactions between p65/RelA and the β-arrestins.” Honeycutt, Christopher, Duke University
Graduate and Post-baccalaureate Students
1st place, “Bromodomain-Containing Protein 4 (BRD4) Inhibitors as Emerging Therapeutics for Opioid Use Disorder.” Silva, Jacqueline, University of Texas Medical Branch
2nd place, “Evaluation of the Terpenes β-caryophyllene, α-terpineol, and γ-terpinene in the Mouse Chronic Constriction Injury Model of Neuropathic Pain: Possible Cannabinoid Receptor Involvement.” Ortiz, Yuma, University of Florida, College of Pharmacy
3rd place, “Optimization of ML321: a D2 dopamine receptor-selective antagonist for the treatment of neuropsychiatric disorders.” Rocereta, Julia, National Institute of Neurological Disorders and Stroke
1st place, “Discovery of Small Molecule Modulators targeting Secretin Receptors.” Dengler, Daniela, SBP Medical Discovery Institute